Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""McWilliam HEG"" wg kryterium: Autor


Wyświetlanie 1-1 z 1
Tytuł:
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
Autorzy:
Rigau M; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.; University of Bonn, Bonn, Germany.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australia.
Ostrouska S; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.
Fulford TS; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
Johnson DN; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australia.
Woods K; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.; Ludwig Institute for Cancer Research, Melbourne -Austin Branch, Victoria 3084, Australia.
Ruan Z; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australia.
McWilliam HEG; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.; Department of Biochemistry and Molecular Biology at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Hudson C; Ludwig Institute for Cancer Research, Melbourne -Austin Branch, Victoria 3084, Australia.
Tutuka C; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.
Wheatley AK; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.; Australian Research Council Centre of Excellence for Convergent Bio-Nano Science and Technology at the University of Melbourne, Victoria 3010, Australia.
Kent SJ; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.; Australian Research Council Centre of Excellence for Convergent Bio-Nano Science and Technology at the University of Melbourne, Victoria 3010, Australia.
Villadangos JA; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.; Department of Biochemistry and Molecular Biology at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Pal B; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.
Kurts C; University of Bonn, Bonn, Germany.
Simmonds J; CSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Pelzing M; CSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Nash AD; CSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Hammet A; CSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Verhagen AM; CSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Vairo G; CSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Maraskovsky E; CSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Panousis C; CSL Limited at the Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Gherardin NA; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia.
Cebon J; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia.; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.; Ludwig Institute for Cancer Research, Melbourne -Austin Branch, Victoria 3084, Australia.; Department of Medicine, The University of Melbourne, Melbourne, Victoria 3010, Australia.; Austin Health, Heidelberg, Victoria 3084, Australia.
Godfrey DI; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia. .; Australian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australia.
Behren A; Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia. .; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria 3084, Australia.; Ludwig Institute for Cancer Research, Melbourne -Austin Branch, Victoria 3084, Australia.; Department of Medicine, The University of Melbourne, Melbourne, Victoria 3010, Australia.
Uldrich AP; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria 3010, Australia. .; Australian Research Council Centre of Excellence for Advanced Molecular Imaging at the University of Melbourne, Victoria 3010, Australia.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2020 Feb 07; Vol. 367 (6478). Date of Electronic Publication: 2020 Jan 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Neoplasm/*immunology
Butyrophilins/*immunology
Receptors, Antigen, T-Cell, gamma-delta/*immunology
T-Lymphocytes/*immunology
Antigens, CD/chemistry ; Antigens, CD/immunology ; Butyrophilins/chemistry ; Butyrophilins/genetics ; Cell Line, Tumor ; Humans ; Ligands ; Lymphocyte Activation ; Phosphorylation ; Protein Domains ; Protein Multimerization
Czasopismo naukowe
    Wyświetlanie 1-1 z 1

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies